The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103695943 10369594 3 F 20160218 20140807 20160922 PER US-AMGEN INC.-USASP2014024459 AMGEN 49.00 YR A F Y 0.00000 20160922 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103695943 10369594 1 PS NEUPOGEN FILGRASTIM 1 Unknown 300 MCG, 1 IN 1 D U 103353 300 UG UNKNOWN FORMULATION QD
103695943 10369594 2 SS NEULASTA PEGFILGRASTIM 1 Unknown 6 MG, UNK U 0 6 MG UNKNOWN FORMULATION
103695943 10369594 3 SS HERCEPTIN TRASTUZUMAB 1 Intravenous (not otherwise specified) 289 MG, 1 IN 1 D 0 289 MG SOLUTION FOR INFUSION QD
103695943 10369594 4 SS HERCEPTIN TRASTUZUMAB 1 Intravenous (not otherwise specified) 145 MG, 1 IN 1 D 0 145 MG SOLUTION FOR INFUSION QD
103695943 10369594 5 C DEXAMETHASONE SODIUM PHOSPHATE. DEXAMETHASONE SODIUM PHOSPHATE 1 Intravenous (not otherwise specified) 20 MG, 1 IN 1 D 0 20 MG QD
103695943 10369594 6 C DEXAMETHASONE SODIUM PHOSPHATE. DEXAMETHASONE SODIUM PHOSPHATE 1 Intravenous (not otherwise specified) 10 MG, UNK 0 10 MG
103695943 10369594 7 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 25 MG, 1 IN 1 D 0 25 MG QD
103695943 10369594 8 C ALOXI PALONOSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.25 MG, 1 IN 1 D 0 .25 MG QD
103695943 10369594 9 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 50 MG, 1 IN 1 D 0 50 MG QD
103695943 10369594 10 C TYLENOL ACETAMINOPHEN 1 Oral 1000 MG, 1 IN 1 D 0 1000 MG QD
103695943 10369594 11 C DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 135 MG, UNK 0 135 MG
103695943 10369594 12 C CARBOPLATIN. CARBOPLATIN 1 758 MG, UNK 0 758 MG
103695943 10369594 13 C CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) 837 MG, UNK 0 837 MG
103695943 10369594 14 C PEPCID FAMOTIDINE 1 Intravenous (not otherwise specified) 20 MG, UNK 0 20 MG
103695943 10369594 15 C INFLUENZA VIRUS VACCINE INFLUENZA VIRUS VACCINE 1 Intramuscular UNK 0
103695943 10369594 16 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 650 MG, 1 IN 1 D 0 650 MG QD
103695943 10369594 17 C DIPHENHYDRAMINE HCL DIPHENHYDRAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 12.5 MG, 1 IN 1 D 0 12.5 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103695943 10369594 1 Product used for unknown indication
103695943 10369594 2 Product used for unknown indication
103695943 10369594 3 Breast cancer female

Outcome of event

Event ID CASEID OUTC COD
103695943 10369594 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
103695943 10369594 Fatigue
103695943 10369594 Pain
103695943 10369594 Platelet count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103695943 10369594 1 20110926 0
103695943 10369594 2 20111122 0
103695943 10369594 3 20110919 0
103695943 10369594 4 20110926 0
103695943 10369594 6 20111219 20111219 0
103695943 10369594 13 20111219 20111219 0
103695943 10369594 15 20111003 0
103695943 10369594 16 20111212 0